tiprankstipranks
Prime Medicine treatment of retinal dystrophy granted orphan designation
The Fly

Prime Medicine treatment of retinal dystrophy granted orphan designation

Prime Medicine’s (PRME) treatment of retinal dystrophy due to USH2A gene mutations was granted FDA orphan designation, according to a post to the agency’s website.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App